rejuvant life tabs

Longevity Escape Velocity within 10 years?

Latest articles

Leucine, weight loss and NAD+ boosting

Part 2 of our interview with NuSirt's founder explores clinical trials and commercialisation of nutraceutical and pharmaceutical combinations with leucine. In the first part of...

Organoid to the rescue of the thyroid

Sci-fi or reality? Artificial organs may soon be the solution for those suffering from all forms of hypothyroidism. The role of the thyroid gland is...

Changing demographics warrant solid longevity foundation

EU Green Paper on Ageing is a wish list, but the European Longevity Initiative is proposing a foundation first. Back in January, the European Commission...

Longevity supplements report: JUVICELL profile

Determined to bring longevity opportunities to a wider market, JUVICELL packs ten ingredients into its longevity supplement. Over the coming weeks, we will be bringing...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...
Supplement report

Editor's picks

Leucine, weight loss and NAD+ boosting

Part 2 of our interview with NuSirt's founder explores clinical trials and commercialisation of nutraceutical and pharmaceutical combinations with leucine. In the first part of...

Organoid to the rescue of the thyroid

Sci-fi or reality? Artificial organs may soon be the solution for those suffering from all forms of hypothyroidism. The role of the thyroid gland is...

Changing demographics warrant solid longevity foundation

EU Green Paper on Ageing is a wish list, but the European Longevity Initiative is proposing a foundation first. Back in January, the European Commission...
Rejuvant

Bestselling book enters new markets and predicts Longevity Escape Velocity by 2029/30.

Back in the 1980s, pop sensation Wham! encouraged us all to “Choose Life”; now a book that argues we will soon hit Longevity Escape Velocity has released its French language edition.

Longevity.Technology: Authors José Luis Cordeiro and David Wood are Longevity floor-fillers who have turned their considerable talents to bookshelf-filling. Both experienced speakers and writers, their combined knowledge of the Longevity field is considerable. Cordeiro is an engineer, economist, futurist and transhumanist, who has worked in different fields including economic development, international relations and is an international member of the World Academy of Arts and Sciences. Wood is the creator of the world’s first operating system for smartphones is on the Board of Directors of the Institute for Ethics and Emerging Technologies.

La Muerte de la Muerte – The Death of Death – was published in 2018 in Spanish. A second edition soon followed, with the book becoming a bestseller in Spain and Latin America. Following the publication of the Portuguese edition – A Morte de Morte which was a bestseller in Portugal and Brazil – a French edition was launched yesterday. The book is also available in Belgium, Switzerland and Luxembourg. Cordeiro and Wood will also be releasing their book in Russian, with an epilogue by Longevity Vision Fund’s Sergey Young, and in Chinese, with other international versions in the works.

The book’s mission is to cover the scientific advances towards immortality. Aging is a disease, the authors tell us, that can be cured and that must be cured. Progress in Longevity research means the death of death is achievable, says Cordeiro.

“In the last few years,” he says “scientists have been able to extend the average lifespan of mice almost twice, the lifespan of mosquitoes four times more, and the lifespan of some worms almost 10 times. This is just the beginning, and we will see much more in life extension and also rejuvenation in the coming years.”

Corderio goes as far as to indicate a timetable. “By 2029/30, so by the end of this decade,” Corderio says “we will have reached Longevity Escape Velocity … This means that for every year we survive, we gain an extra year, but we will still age. Living longer, but still aging.

Elevant

“We believe that death will be optional by 2045, or even earlier, if more public and private funds are invested in rejuvenation technologies,” he says. “Thanks to exponential advances in artificial intelligence, tissue regeneration, stem cell treatments, organ printing, cryopreservation, genetic or immunological therapies will solve – and are already solving – the problem of aging of the human body. By 2045, technology for rejuvenation will be very, very cheap.”

 


 

“Longevity research is breaking [that dogma] by repairing aging damage and slowing aging and even reversing it.”

 


 

For the authors, the proof that biological immortality is possible is that it already exists. “Some multicellular organisms like Hydras and some species of Jellyfish do not seem to undergo any senescence and, as such, can potentially be considered to be biologically immortal, as long as they are not eaten or killed. Planarian flatworms appear to regenerate indefinitely and seem to have an apparently limitless telomere regenerative capacity fuelled by highly proliferative adult stem cells. Therefore, not just unicellular bacteria and gametes but also some multicellular organisms have a lot to teach about indefinite longevity. They are the living proof that senescence is not a compulsory by-product of being alive.

It comes down to a mental block, explains Cordeiro. “No-one likes to think about death, let alone their own death; we have a death mindset, but Longevity research is breaking that dogma by repairing aging damage and slowing aging and even reversing it.

Elevant

“Our book seeks to change the public perception of aging, to disrupt the paradigm of accepting aging and death as inevitable consequences of life, to bring about the death of death itself.”

The Death of Death is available from Amazon in Spanish, Portuguese and French.

Images credit: Cindy Lever from Pixabay
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
Rejuvant

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Supplement report

Related articles

New investor offers funding to healthy aging innovators

A fifth investor has joined UK Research and Innovation (UKRI), providing matched funding for top small innovators to develop ideas for healthy aging. The new...

Connected care start-up targets aging-in-place

PCL Health monitors key vitals at home, providing caregivers with peace of mind and supporting aging-in-place. British start-up PCL Health (formerly Poonyah Care) is on...

AgeTech fund: focus on over-50s not millennials

Founding partner of 1843 Capital targets AgeTech investment opportunities with $13 million fund. Connecticut-based early stage investment firm 1843 Capital values diversity highly, and seeks...

Gut bacteria start-up exits stealth with unique data

Wild Biotech plans to use database of more than 1,200 gut microbes to pursue novel drugs for human diseases and enhance CRISPR editing. Wild Biotech,...

AI first: novel drug target and novel molecule discovered

One step closer to senescence moonshot: Insilico claims industry first by nominating preclinical candidate for IPF, with both novel drug target and novel molecule...
Supps report ad middle